Weaning from mechanical ventilation in people with neuromuscular disease: a systematic review
Author
dc.contributor.author
Gomes Bernardes Neto, Saint Clair
Author
dc.contributor.author
Torres, Rodrigo
Author
dc.contributor.author
Lima, Illia
Author
dc.contributor.author
Resqueti, Vanessa R.
Admission date
dc.date.accessioned
2022-01-07T15:38:58Z
Available date
dc.date.available
2022-01-07T15:38:58Z
Publication date
dc.date.issued
2021
Cita de ítem
dc.identifier.citation
BMJ Open 2021;11:e047449
es_ES
Identifier
dc.identifier.other
10.1136/bmjopen-2020-047449
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/183496
Abstract
dc.description.abstract
Objective This systematic review aimed in assessing the effects of different weaning protocols in people with neuromuscular disease (NMD) receiving invasive mechanical ventilation, identifying which protocol is the best and how different protocols can affect weaning outcome success, duration of weaning, intensive care unit (ICU) and hospital stay and mortality. Design Systematic review. Data sources Electronic databases (MEDLINE, EMBASE, Web of Science and Scopus) were searched from January 2009 to August 2020. Eligibility criteria for selecting studies Randomised controlled trials (RCTs) and non-RCT that evaluated patients with NMD (adults and children from 5 years old) in the weaning process managed with a protocol (pressure support ventilation; synchronised intermittent mandatory ventilation; continuous positive airway pressure; 'T' piece). Primary outcome Weaning success. Secondary outcomes Weaning duration, ICU stay, hospital stay, ICU mortality, complications (pneumothorax, ventilation-associated pneumonia). Data extraction and synthesis Two review authors assessed the titles and the abstracts for inclusion and reviewed the full texts independently. Results We found no studies that fulfilled the inclusion criteria. Conclusions The absence of studies about different weaning protocols for patients with NMD does not allow concluding the superiority of any specific weaning protocol for patients with NMD or determining the impact of different types of protocols on other outcomes. The result of this review encourages further studies.
es_ES
Patrocinador
dc.description.sponsorship
Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
054/2014 -23038.007514/2014-78
Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) 312876/2018-1
315580/2018-6
es_ES
Lenguage
dc.language.iso
en
es_ES
Publisher
dc.publisher
BMJ
es_ES
Type of license
dc.rights
Attribution-NonCommercial-NoDerivs 3.0 United States